nodes	percent_of_prediction	percent_of_DWPC	metapath
Mesalazine—PPARG—forelimb—Parkinson's disease	0.0263	0.115	CbGeAlD
Mesalazine—Carbidopa—DDC—Parkinson's disease	0.0135	0.259	CrCbGaD
Mesalazine—CHUK—cardiovascular system—Parkinson's disease	0.0119	0.0523	CbGeAlD
Mesalazine—IKBKB—embryo—Parkinson's disease	0.0108	0.0475	CbGeAlD
Mesalazine—IKBKB—cardiovascular system—Parkinson's disease	0.0081	0.0355	CbGeAlD
Mesalazine—CHUK—head—Parkinson's disease	0.00807	0.0354	CbGeAlD
Mesalazine—Methyldopa—DDC—Parkinson's disease	0.00722	0.138	CrCbGaD
Mesalazine—CHUK—cerebellum—Parkinson's disease	0.0072	0.0316	CbGeAlD
Mesalazine—PPARG—embryo—Parkinson's disease	0.00674	0.0296	CbGeAlD
Mesalazine—MPO—forebrain—Parkinson's disease	0.00672	0.0295	CbGeAlD
Mesalazine—ALOX5—cardiovascular system—Parkinson's disease	0.00671	0.0295	CbGeAlD
Mesalazine—PPARG—forebrain—Parkinson's disease	0.00596	0.0262	CbGeAlD
Mesalazine—CHUK—brain—Parkinson's disease	0.00585	0.0257	CbGeAlD
Mesalazine—MPO—cardiovascular system—Parkinson's disease	0.00568	0.0249	CbGeAlD
Mesalazine—IKBKB—head—Parkinson's disease	0.00549	0.0241	CbGeAlD
Mesalazine—IKBKB—nervous system—Parkinson's disease	0.0052	0.0228	CbGeAlD
Mesalazine—PPARG—cardiovascular system—Parkinson's disease	0.00504	0.0221	CbGeAlD
Mesalazine—IKBKB—central nervous system—Parkinson's disease	0.00501	0.022	CbGeAlD
Mesalazine—IKBKB—cerebellum—Parkinson's disease	0.00489	0.0215	CbGeAlD
Mesalazine—Dopamine—DBH—Parkinson's disease	0.00465	0.0892	CrCbGaD
Mesalazine—ALOX5—head—Parkinson's disease	0.00455	0.0199	CbGeAlD
Mesalazine—Droxidopa—DDC—Parkinson's disease	0.0045	0.0864	CrCbGaD
Mesalazine—MPO—spinal cord—Parkinson's disease	0.00433	0.019	CbGeAlD
Mesalazine—ALOX5—nervous system—Parkinson's disease	0.00431	0.0189	CbGeAlD
Mesalazine—ALOX5—central nervous system—Parkinson's disease	0.00415	0.0182	CbGeAlD
Mesalazine—ALOX5—cerebellum—Parkinson's disease	0.00406	0.0178	CbGeAlD
Mesalazine—IKBKB—brain—Parkinson's disease	0.00397	0.0174	CbGeAlD
Mesalazine—MPO—head—Parkinson's disease	0.00385	0.0169	CbGeAlD
Mesalazine—L-DOPA—DDC—Parkinson's disease	0.00379	0.0727	CrCbGaD
Mesalazine—MPO—nervous system—Parkinson's disease	0.00365	0.016	CbGeAlD
Mesalazine—MPO—central nervous system—Parkinson's disease	0.00351	0.0154	CbGeAlD
Mesalazine—PTGS2—embryo—Parkinson's disease	0.00344	0.0151	CbGeAlD
Mesalazine—PPARG—head—Parkinson's disease	0.00341	0.015	CbGeAlD
Mesalazine—ALOX5—brain—Parkinson's disease	0.00329	0.0145	CbGeAlD
Mesalazine—PPARG—nervous system—Parkinson's disease	0.00324	0.0142	CbGeAlD
Mesalazine—Methyldopa—COMT—Parkinson's disease	0.00322	0.0618	CrCbGaD
Mesalazine—PTGS1—forebrain—Parkinson's disease	0.00319	0.014	CbGeAlD
Mesalazine—PPARG—central nervous system—Parkinson's disease	0.00312	0.0137	CbGeAlD
Mesalazine—PTGS2—forebrain—Parkinson's disease	0.00305	0.0134	CbGeAlD
Mesalazine—MPO—brain—Parkinson's disease	0.00279	0.0122	CbGeAlD
Mesalazine—PTGS1—cardiovascular system—Parkinson's disease	0.00269	0.0118	CbGeAlD
Mesalazine—PTGS2—cardiovascular system—Parkinson's disease	0.00258	0.0113	CbGeAlD
Mesalazine—PPARG—brain—Parkinson's disease	0.00247	0.0109	CbGeAlD
Mesalazine—PTGS2—medulla oblongata—Parkinson's disease	0.0022	0.00966	CbGeAlD
Mesalazine—PTGS1—spinal cord—Parkinson's disease	0.00205	0.00901	CbGeAlD
Mesalazine—PTGS2—midbrain—Parkinson's disease	0.00201	0.00883	CbGeAlD
Mesalazine—PTGS2—spinal cord—Parkinson's disease	0.00196	0.00861	CbGeAlD
Mesalazine—PTGS1—head—Parkinson's disease	0.00182	0.00801	CbGeAlD
Mesalazine—PTGS2—head—Parkinson's disease	0.00174	0.00765	CbGeAlD
Mesalazine—PTGS1—nervous system—Parkinson's disease	0.00173	0.00759	CbGeAlD
Mesalazine—Dopamine—MAOB—Parkinson's disease	0.00169	0.0325	CrCbGaD
Mesalazine—PTGS1—central nervous system—Parkinson's disease	0.00167	0.00731	CbGeAlD
Mesalazine—PTGS2—nervous system—Parkinson's disease	0.00165	0.00725	CbGeAlD
Mesalazine—PTGS2—central nervous system—Parkinson's disease	0.00159	0.00698	CbGeAlD
Mesalazine—Dopamine—COMT—Parkinson's disease	0.00157	0.0302	CrCbGaD
Mesalazine—PTGS2—cerebellum—Parkinson's disease	0.00156	0.00683	CbGeAlD
Mesalazine—PTGS1—brain—Parkinson's disease	0.00132	0.0058	CbGeAlD
Mesalazine—PTGS2—brain—Parkinson's disease	0.00126	0.00555	CbGeAlD
Mesalazine—Dopamine—MAOA—Parkinson's disease	0.00119	0.0228	CrCbGaD
Mesalazine—L-DOPA—DRD3—Parkinson's disease	0.00118	0.0227	CrCbGaD
Mesalazine—Dopamine—HTR7—Parkinson's disease	0.00117	0.0224	CrCbGaD
Mesalazine—L-DOPA—DRD1—Parkinson's disease	0.00116	0.0223	CrCbGaD
Mesalazine—Dopamine—DRD3—Parkinson's disease	0.0011	0.0211	CrCbGaD
Mesalazine—Dopamine—DRD1—Parkinson's disease	0.00108	0.0207	CrCbGaD
Mesalazine—Dopamine—SLC6A3—Parkinson's disease	0.00102	0.0196	CrCbGaD
Mesalazine—Dopamine—HTR1A—Parkinson's disease	0.000897	0.0172	CrCbGaD
Mesalazine—L-DOPA—DRD2—Parkinson's disease	0.000819	0.0157	CrCbGaD
Mesalazine—Dopamine—DRD2—Parkinson's disease	0.000761	0.0146	CrCbGaD
Mesalazine—L-DOPA—CYP2D6—Parkinson's disease	0.000579	0.0111	CrCbGaD
Mesalazine—Dopamine—CYP2D6—Parkinson's disease	0.000538	0.0103	CrCbGaD
Mesalazine—Salicylic acid—ABCB1—Parkinson's disease	0.000462	0.00885	CrCbGaD
Mesalazine—ALOX5—Metabolism—CTGF—Parkinson's disease	0.00028	0.000389	CbGpPWpGaD
Mesalazine—PPARG—Gene Expression—RPS8—Parkinson's disease	0.000279	0.000388	CbGpPWpGaD
Mesalazine—PPARG—Adipogenesis—IL6—Parkinson's disease	0.000275	0.000382	CbGpPWpGaD
Mesalazine—IKBKB—Regulation of toll-like receptor signaling pathway—TNF—Parkinson's disease	0.000275	0.000382	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.000272	0.000378	CbGpPWpGaD
Mesalazine—CHUK—Toll Like Receptor 4 (TLR4) Cascade—IL6—Parkinson's disease	0.000271	0.000377	CbGpPWpGaD
Mesalazine—IKBKB—Signaling by Interleukins—IL6—Parkinson's disease	0.000271	0.000377	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—ABL1—Parkinson's disease	0.000271	0.000377	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—FBP1—Parkinson's disease	0.000269	0.000374	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—DBH—Parkinson's disease	0.000269	0.000374	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—GBA—Parkinson's disease	0.000269	0.000374	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—GRK5—Parkinson's disease	0.000269	0.000373	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—HLA-DRA—Parkinson's disease	0.000267	0.00037	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—GSTA4—Parkinson's disease	0.000266	0.00037	CbGpPWpGaD
Mesalazine—CHUK—Immune System—PARK2—Parkinson's disease	0.000266	0.000369	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—TALDO1—Parkinson's disease	0.000265	0.000368	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—OMD—Parkinson's disease	0.000265	0.000368	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—PLA2G6—Parkinson's disease	0.000264	0.000367	CbGpPWpGaD
Mesalazine—CHUK—Immune System—FGF20—Parkinson's disease	0.000264	0.000366	CbGpPWpGaD
Mesalazine—PTGS1—Selenium Micronutrient Network—IL6—Parkinson's disease	0.000263	0.000365	CbGpPWpGaD
Mesalazine—PPARG—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.000263	0.000365	CbGpPWpGaD
Mesalazine—IKBKB—Activated TLR4 signalling—IL6—Parkinson's disease	0.000262	0.000363	CbGpPWpGaD
Mesalazine—CHUK—Disease—RPL23A—Parkinson's disease	0.000261	0.000362	CbGpPWpGaD
Mesalazine—CHUK—Disease—RPL14—Parkinson's disease	0.000261	0.000362	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—CYP2E1—Parkinson's disease	0.000261	0.000362	CbGpPWpGaD
Mesalazine—PTGS2—Selenium Micronutrient Network—TNF—Parkinson's disease	0.000259	0.000359	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—NQO1—Parkinson's disease	0.000258	0.000358	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—RIT2—Parkinson's disease	0.000257	0.000357	CbGpPWpGaD
Mesalazine—PTGS2—Disease—FBP1—Parkinson's disease	0.000255	0.000354	CbGpPWpGaD
Mesalazine—PTGS2—Disease—TAF1—Parkinson's disease	0.000255	0.000354	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—TH—Parkinson's disease	0.000254	0.000353	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—NDUFB11—Parkinson's disease	0.000251	0.000349	CbGpPWpGaD
Mesalazine—IKBKB—Toll Like Receptor 4 (TLR4) Cascade—IL6—Parkinson's disease	0.000246	0.000342	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—ABL1—Parkinson's disease	0.000246	0.000341	CbGpPWpGaD
Mesalazine—CHUK—Regulation of toll-like receptor signaling pathway—IL6—Parkinson's disease	0.000244	0.00034	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—CYCS—Parkinson's disease	0.000244	0.000339	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—GRK5—Parkinson's disease	0.000244	0.000339	CbGpPWpGaD
Mesalazine—CHUK—Disease—FGF20—Parkinson's disease	0.000243	0.000338	CbGpPWpGaD
Mesalazine—CHUK—Disease—RPS8—Parkinson's disease	0.000243	0.000338	CbGpPWpGaD
Mesalazine—CHUK—Toll-Like Receptors Cascades—IL6—Parkinson's disease	0.000242	0.000336	CbGpPWpGaD
Mesalazine—CHUK—Signaling by SCF-KIT—IL6—Parkinson's disease	0.000242	0.000336	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—GRM4—Parkinson's disease	0.000241	0.000335	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—PARK2—Parkinson's disease	0.000241	0.000335	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—PLA2G6—Parkinson's disease	0.00024	0.000333	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—GCH1—Parkinson's disease	0.00024	0.000333	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—FGF20—Parkinson's disease	0.000239	0.000332	CbGpPWpGaD
Mesalazine—CHUK—Cytokine Signaling in Immune system—IL1B—Parkinson's disease	0.000238	0.000331	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—MAOB—Parkinson's disease	0.000237	0.00033	CbGpPWpGaD
Mesalazine—IKBKB—MAPK Signaling Pathway—TNF—Parkinson's disease	0.000236	0.000328	CbGpPWpGaD
Mesalazine—CHUK—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	0.000235	0.000326	CbGpPWpGaD
Mesalazine—CHUK—Signaling by NGF—CASP3—Parkinson's disease	0.000234	0.000325	CbGpPWpGaD
Mesalazine—CHUK—Downstream signaling of activated FGFR—IL6—Parkinson's disease	0.000231	0.000321	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—PENK—Parkinson's disease	0.000229	0.000317	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—MAG—Parkinson's disease	0.000229	0.000317	CbGpPWpGaD
Mesalazine—CHUK—Signaling by ERBB4—IL6—Parkinson's disease	0.000228	0.000316	CbGpPWpGaD
Mesalazine—PPARG—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.000226	0.000314	CbGpPWpGaD
Mesalazine—PPARG—Gene Expression—HSPA8—Parkinson's disease	0.000224	0.000311	CbGpPWpGaD
Mesalazine—PPARG—Gene Expression—CTGF—Parkinson's disease	0.000223	0.000309	CbGpPWpGaD
Mesalazine—IKBKB—Regulation of toll-like receptor signaling pathway—IL6—Parkinson's disease	0.000222	0.000308	CbGpPWpGaD
Mesalazine—IKBKB—Toll-Like Receptors Cascades—IL6—Parkinson's disease	0.000219	0.000304	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—GRM4—Parkinson's disease	0.000219	0.000304	CbGpPWpGaD
Mesalazine—CHUK—Downstream signal transduction—IL6—Parkinson's disease	0.000217	0.000302	CbGpPWpGaD
Mesalazine—CHUK—Signaling by FGFR—IL6—Parkinson's disease	0.000216	0.0003	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.000216	0.0003	CbGpPWpGaD
Mesalazine—IKBKB—Cytokine Signaling in Immune system—IL1B—Parkinson's disease	0.000216	0.0003	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—INS—Parkinson's disease	0.000216	0.0003	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—COMT—Parkinson's disease	0.000216	0.0003	CbGpPWpGaD
Mesalazine—CHUK—Signaling by ERBB2—IL6—Parkinson's disease	0.000215	0.000299	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—GSTP1—Parkinson's disease	0.000215	0.000299	CbGpPWpGaD
Mesalazine—CHUK—Signaling by NGF—MAPK8—Parkinson's disease	0.000215	0.000299	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—MAOA—Parkinson's disease	0.000214	0.000298	CbGpPWpGaD
Mesalazine—CHUK—DAP12 signaling—IL6—Parkinson's disease	0.000214	0.000297	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—GBA—Parkinson's disease	0.000214	0.000297	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—FBP1—Parkinson's disease	0.000214	0.000297	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—DBH—Parkinson's disease	0.000214	0.000297	CbGpPWpGaD
Mesalazine—IKBKB—Signaling by NGF—CASP3—Parkinson's disease	0.000212	0.000295	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—HMOX1—Parkinson's disease	0.000212	0.000294	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—PDYN—Parkinson's disease	0.000209	0.00029	CbGpPWpGaD
Mesalazine—PTGS2—Selenium Micronutrient Network—IL6—Parkinson's disease	0.000209	0.00029	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—PENK—Parkinson's disease	0.000207	0.000288	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—MAG—Parkinson's disease	0.000207	0.000288	CbGpPWpGaD
Mesalazine—PTGS2—Spinal Cord Injury—TNF—Parkinson's disease	0.000205	0.000284	CbGpPWpGaD
Mesalazine—PTGS2—Disease—RPL6—Parkinson's disease	0.000204	0.000283	CbGpPWpGaD
Mesalazine—PTGS2—Disease—SNCA—Parkinson's disease	0.000204	0.000283	CbGpPWpGaD
Mesalazine—PPARG—Gene Expression—HSPA1A—Parkinson's disease	0.000204	0.000283	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—ABCB1—Parkinson's disease	0.000203	0.000283	CbGpPWpGaD
Mesalazine—CHUK—Signaling by FGFR in disease—IL6—Parkinson's disease	0.000201	0.00028	CbGpPWpGaD
Mesalazine—CHUK—DAP12 interactions—IL6—Parkinson's disease	0.000201	0.00028	CbGpPWpGaD
Mesalazine—CHUK—Fc epsilon receptor (FCERI) signaling—IL6—Parkinson's disease	0.000201	0.00028	CbGpPWpGaD
Mesalazine—CHUK—Signaling by EGFR—IL6—Parkinson's disease	0.0002	0.000277	CbGpPWpGaD
Mesalazine—CHUK—Signaling by EGFR in Cancer—IL6—Parkinson's disease	0.000198	0.000275	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—GSTM1—Parkinson's disease	0.000198	0.000274	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—DDC—Parkinson's disease	0.000198	0.000274	CbGpPWpGaD
Mesalazine—CHUK—Signaling by PDGF—IL6—Parkinson's disease	0.000197	0.000274	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—GFAP—Parkinson's disease	0.000197	0.000273	CbGpPWpGaD
Mesalazine—IKBKB—Signaling by NGF—MAPK8—Parkinson's disease	0.000195	0.000271	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—GRM5—Parkinson's disease	0.000194	0.00027	CbGpPWpGaD
Mesalazine—PPARG—Circadian rythm related genes—IL6—Parkinson's disease	0.000194	0.000269	CbGpPWpGaD
Mesalazine—CHUK—Immune System—ADRBK1—Parkinson's disease	0.000194	0.000269	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—Parkinson's disease	0.000191	0.000266	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—PDYN—Parkinson's disease	0.00019	0.000263	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—GPX1—Parkinson's disease	0.000189	0.000263	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—GSTA4—Parkinson's disease	0.000187	0.000259	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.000184	0.000256	CbGpPWpGaD
Mesalazine—IKBKB—Fc epsilon receptor (FCERI) signaling—IL6—Parkinson's disease	0.000183	0.000254	CbGpPWpGaD
Mesalazine—CHUK—Disease—ADRBK1—Parkinson's disease	0.000179	0.000248	CbGpPWpGaD
Mesalazine—CHUK—NGF signalling via TRKA from the plasma membrane—IL6—Parkinson's disease	0.000178	0.000248	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—GFAP—Parkinson's disease	0.000178	0.000248	CbGpPWpGaD
Mesalazine—CHUK—Disease—HSPA1A—Parkinson's disease	0.000178	0.000247	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—CYP2D6—Parkinson's disease	0.000176	0.000245	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—GRM5—Parkinson's disease	0.000176	0.000245	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	0.000176	0.000244	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—ADRBK1—Parkinson's disease	0.000176	0.000244	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—MTHFR—Parkinson's disease	0.000175	0.000242	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—CTGF—Parkinson's disease	0.000173	0.00024	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—FGF20—Parkinson's disease	0.00017	0.000237	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—PLA2G6—Parkinson's disease	0.000168	0.000233	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—MAOB—Parkinson's disease	0.000166	0.000231	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—ADORA2A—Parkinson's disease	0.000165	0.00023	CbGpPWpGaD
Mesalazine—PTGS2—Spinal Cord Injury—IL6—Parkinson's disease	0.000165	0.000229	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—APOE—Parkinson's disease	0.000163	0.000226	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—CYP2E1—Parkinson's disease	0.000161	0.000224	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—NQO1—Parkinson's disease	0.00016	0.000222	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.000158	0.00022	CbGpPWpGaD
Mesalazine—CHUK—Immune System—ABL1—Parkinson's disease	0.000158	0.000219	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—TH—Parkinson's disease	0.000157	0.000218	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—DDC—Parkinson's disease	0.000157	0.000218	CbGpPWpGaD
Mesalazine—PTGS2—Disease—RPL23A—Parkinson's disease	0.000155	0.000215	CbGpPWpGaD
Mesalazine—PTGS2—Disease—RPL14—Parkinson's disease	0.000155	0.000215	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—FGF20—Parkinson's disease	0.000155	0.000215	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—INSR—Parkinson's disease	0.000152	0.000212	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—CYCS—Parkinson's disease	0.000151	0.00021	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—ADORA2A—Parkinson's disease	0.00015	0.000208	CbGpPWpGaD
Mesalazine—CHUK—Immune System—HGF—Parkinson's disease	0.000148	0.000206	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—GSTA4—Parkinson's disease	0.000148	0.000206	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.000146	0.000203	CbGpPWpGaD
Mesalazine—PTGS2—Disease—RPS8—Parkinson's disease	0.000144	0.0002	CbGpPWpGaD
Mesalazine—PTGS2—Disease—FGF20—Parkinson's disease	0.000144	0.0002	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—FGB—Parkinson's disease	0.000144	0.0002	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—HTR1A—Parkinson's disease	0.000143	0.000199	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—ABL1—Parkinson's disease	0.000143	0.000199	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—TAC1—Parkinson's disease	0.000141	0.000196	CbGpPWpGaD
Mesalazine—CHUK—Cytokine Signaling in Immune system—IL6—Parkinson's disease	0.00014	0.000194	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	0.000139	0.000193	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—INS—Parkinson's disease	0.000139	0.000193	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—DRD1—Parkinson's disease	0.000138	0.000192	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—INSR—Parkinson's disease	0.000138	0.000192	CbGpPWpGaD
Mesalazine—CHUK—Signaling by NGF—IL6—Parkinson's disease	0.000137	0.000191	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—HGF—Parkinson's disease	0.000135	0.000187	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—DRD3—Parkinson's disease	0.000134	0.000186	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—COMT—Parkinson's disease	0.000134	0.000186	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—PLA2G6—Parkinson's disease	0.000133	0.000185	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—GSTP1—Parkinson's disease	0.000133	0.000185	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—MAOA—Parkinson's disease	0.000133	0.000184	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—MAOB—Parkinson's disease	0.000132	0.000183	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—HMOX1—Parkinson's disease	0.000131	0.000182	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—FGB—Parkinson's disease	0.000131	0.000182	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—HTR1A—Parkinson's disease	0.00013	0.000181	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—TAC1—Parkinson's disease	0.000128	0.000178	CbGpPWpGaD
Mesalazine—IKBKB—Cytokine Signaling in Immune system—IL6—Parkinson's disease	0.000127	0.000176	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—ABCB1—Parkinson's disease	0.000126	0.000175	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.000126	0.000174	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—DRD1—Parkinson's disease	0.000126	0.000174	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—ADRBK1—Parkinson's disease	0.000125	0.000174	CbGpPWpGaD
Mesalazine—IKBKB—Signaling by NGF—IL6—Parkinson's disease	0.000124	0.000173	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—CYP2D6—Parkinson's disease	0.000124	0.000172	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—MAPK8—Parkinson's disease	0.000123	0.00017	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—GSTM1—Parkinson's disease	0.000122	0.00017	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—DRD3—Parkinson's disease	0.000122	0.000169	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—CTGF—Parkinson's disease	0.000121	0.000168	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—DRD2—Parkinson's disease	0.000121	0.000168	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—HTR7—Parkinson's disease	0.000121	0.000168	CbGpPWpGaD
Mesalazine—CHUK—Disease—MTHFR—Parkinson's disease	0.000121	0.000168	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—GPX1—Parkinson's disease	0.000117	0.000163	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—TNF—Parkinson's disease	0.000117	0.000163	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—ADRBK1—Parkinson's disease	0.000114	0.000158	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—CYP2E1—Parkinson's disease	0.000113	0.000157	CbGpPWpGaD
Mesalazine—CHUK—Disease—APOE—Parkinson's disease	0.000113	0.000157	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—NQO1—Parkinson's disease	0.000112	0.000155	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—MAPK8—Parkinson's disease	0.000111	0.000154	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—TH—Parkinson's disease	0.00011	0.000153	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—HTR7—Parkinson's disease	0.00011	0.000153	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—DRD2—Parkinson's disease	0.00011	0.000153	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—MTHFR—Parkinson's disease	0.000108	0.00015	CbGpPWpGaD
Mesalazine—PTGS2—Disease—ADRBK1—Parkinson's disease	0.000106	0.000147	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—CYCS—Parkinson's disease	0.000106	0.000147	CbGpPWpGaD
Mesalazine—PTGS2—Disease—HSPA1A—Parkinson's disease	0.000105	0.000146	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—IGF2—Parkinson's disease	0.000102	0.000141	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—APOE—Parkinson's disease	0.000101	0.00014	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—IGF1R—Parkinson's disease	9.83e-05	0.000136	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—CYP2D6—Parkinson's disease	9.81e-05	0.000136	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—EDN1—Parkinson's disease	9.71e-05	0.000135	CbGpPWpGaD
Mesalazine—CHUK—Disease—INS—Parkinson's disease	9.63e-05	0.000134	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—CTGF—Parkinson's disease	9.63e-05	0.000134	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—IL6—Parkinson's disease	9.44e-05	0.000131	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—COMT—Parkinson's disease	9.36e-05	0.00013	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—GSTP1—Parkinson's disease	9.32e-05	0.000129	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—MAOA—Parkinson's disease	9.3e-05	0.000129	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—IGF2—Parkinson's disease	9.22e-05	0.000128	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—HMOX1—Parkinson's disease	9.19e-05	0.000128	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—CYP2E1—Parkinson's disease	8.97e-05	0.000125	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—NGF—Parkinson's disease	8.92e-05	0.000124	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—IGF1R—Parkinson's disease	8.91e-05	0.000124	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—NQO1—Parkinson's disease	8.87e-05	0.000123	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—ABCB1—Parkinson's disease	8.82e-05	0.000123	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—EDN1—Parkinson's disease	8.8e-05	0.000122	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—TH—Parkinson's disease	8.74e-05	0.000121	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—INS—Parkinson's disease	8.59e-05	0.000119	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—GSTM1—Parkinson's disease	8.57e-05	0.000119	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—HTR2A—Parkinson's disease	8.49e-05	0.000118	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—CYCS—Parkinson's disease	8.39e-05	0.000117	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—GPX1—Parkinson's disease	8.2e-05	0.000114	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—NGF—Parkinson's disease	8.09e-05	0.000112	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—APOE—Parkinson's disease	7.9e-05	0.00011	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—IL6—Parkinson's disease	7.83e-05	0.000109	CbGpPWpGaD
Mesalazine—CHUK—Immune System—IL1B—Parkinson's disease	7.79e-05	0.000108	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—HTR2A—Parkinson's disease	7.7e-05	0.000107	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—MTHFR—Parkinson's disease	7.57e-05	0.000105	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—COMT—Parkinson's disease	7.43e-05	0.000103	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—GSTP1—Parkinson's disease	7.4e-05	0.000103	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—MAOA—Parkinson's disease	7.38e-05	0.000103	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—HMOX1—Parkinson's disease	7.3e-05	0.000101	CbGpPWpGaD
Mesalazine—PTGS2—Disease—MTHFR—Parkinson's disease	7.18e-05	9.97e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—APOE—Parkinson's disease	7.16e-05	9.95e-05	CbGpPWpGaD
Mesalazine—CHUK—Immune System—MAPK8—Parkinson's disease	7.14e-05	9.92e-05	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—IL6—Parkinson's disease	7.1e-05	9.86e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—IL1B—Parkinson's disease	7.06e-05	9.81e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—APOE—Parkinson's disease	7.05e-05	9.79e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—ABCB1—Parkinson's disease	7e-05	9.73e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—GSTM1—Parkinson's disease	6.8e-05	9.44e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—INS—Parkinson's disease	6.75e-05	9.37e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—APOE—Parkinson's disease	6.68e-05	9.28e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—GPX1—Parkinson's disease	6.51e-05	9.04e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—MAPK8—Parkinson's disease	6.47e-05	8.99e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—INS—Parkinson's disease	6.12e-05	8.5e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—INS—Parkinson's disease	6.02e-05	8.36e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—MTHFR—Parkinson's disease	6.01e-05	8.35e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—INS—Parkinson's disease	5.71e-05	7.93e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—APOE—Parkinson's disease	5.59e-05	7.77e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CASP3—Parkinson's disease	5.02e-05	6.98e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—INS—Parkinson's disease	4.78e-05	6.64e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—MAPK8—Parkinson's disease	4.62e-05	6.41e-05	CbGpPWpGaD
Mesalazine—CHUK—Immune System—IL6—Parkinson's disease	4.56e-05	6.33e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CASP3—Parkinson's disease	4.55e-05	6.33e-05	CbGpPWpGaD
Mesalazine—CHUK—Disease—IL6—Parkinson's disease	4.21e-05	5.85e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—MAPK8—Parkinson's disease	4.19e-05	5.81e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—IL6—Parkinson's disease	4.13e-05	5.74e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—IL6—Parkinson's disease	2.95e-05	4.09e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—IL6—Parkinson's disease	2.67e-05	3.71e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—IL6—Parkinson's disease	2.49e-05	3.46e-05	CbGpPWpGaD
